Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parikh

Showing results (371-380 of 399) with videos related to

Pageof 40
Sort By:
Med (New York, N.Y.)|July 28, 2021
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosisNaoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, et al.
Hepatology (Baltimore, Md.)|November 15, 2021
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesSumeet K Asrani, Marwan S Ghabril, Alexander Kuo, et al.
Cancer|July 7, 2022
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinomaNeehar D Parikh, Neil Mehta, Maarouf A Hoteit, et al.
Bioorganic & Medicinal Chemistry|March 28, 2007
Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimizationSrinivasan R Nagarajan, Hwang-Fun Lu, Alan F Gasiecki, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for SchizophreniaAmy B Dounay, Marie Anderson, Bruce M Bechle, et al.
Hepatology Communications|March 7, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter studyAmit G Singal, T Tara Ghaziani, Neil Mehta, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMayur Brahmania, Alexander Kuo, Elliot B Tapper, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic RegionsHidenori Toyoda, Yujin Hoshida, Neehar D Parikh, et al.
Pageof 40

Showing results (371-380 of 399) with videos related to

Sort By:
Pageof 40
Med (New York, N.Y.)|July 28, 2021
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosisNaoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, et al.
Hepatology (Baltimore, Md.)|November 15, 2021
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesSumeet K Asrani, Marwan S Ghabril, Alexander Kuo, et al.
Cancer|July 7, 2022
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinomaNeehar D Parikh, Neil Mehta, Maarouf A Hoteit, et al.
Bioorganic & Medicinal Chemistry|March 28, 2007
Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimizationSrinivasan R Nagarajan, Hwang-Fun Lu, Alan F Gasiecki, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for SchizophreniaAmy B Dounay, Marie Anderson, Bruce M Bechle, et al.
Hepatology Communications|March 7, 2023
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter studyAmit G Singal, T Tara Ghaziani, Neil Mehta, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMayur Brahmania, Alexander Kuo, Elliot B Tapper, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic RegionsHidenori Toyoda, Yujin Hoshida, Neehar D Parikh, et al.
Pageof 40